Emrah Ozdemir

Dr. Emrah Ozdemir

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
MZMurat Ziyrek
Murat Ziyrek
SKSerkan Kahraman
Serkan Kahraman
EOEmrah Ozdemir
Emrah Ozdemir
ADAli Dogan
Ali Dogan
Imbalance between pro- and anti-inflammatory cytokines secreted from visceral adipose tissue (VAT) contributes to the pathogenesis of certain cardiovascular and metabolic disorders, including insulin resistance. Epicardial adipose tissue (EAT) is a form of VAT mainly concentrated along the coronary arteries. It has been shown in various studies that EAT thickness is positively correlated with cardiovascular disease. Due to its high worldwide prevalence, prevention and management of type 2 diabetes (T2D) has become a major public health challenge. Metformin, the most widely prescribed drug to treat T2D, has favorable effects on VAT and body weight. As metformin decreases VAT mass, in this prospective study we analyzed the possible positive effect of metformin on EAT mass, which is organ-specific VAT, and body mass index (BMI). Subjects were selected from patients admitted to the internal medicine outpatient clinic. Newly diagnosed T2D patients treated with metformin monotherapy were analyzed and 40 patients were included. EAT thickness in the included patients was measured echocardiographically. BMI and EAT thickness were analyzed at the beginning (BMI0 and EAT0) and after three months of metformin monotherapy (BMI3 and EAT3). There was a statistically significant decrease in EAT thickness after three months of metformin monotherapy (EAT0=5.07±1.33 mm vs. EAT3=4.76±1.32 mm; p<0.001). Furthermore, BMI was also significantly decreased (BMI0=28.27±2.71 vs. BMI3=27.29±2.10; p<0.0001). In this study we show that metformin monotherapy significantly decreases EAT thickness and BMI in T2D patients. This suggests that metformin could reduce the frequency of coronary atherosclerosis.

1 June 2019 in Revista Portuguesa de Cardiologia (English Edition)
Verified
Journal Article
Open access
MZMurat Ziyrek
Murat Ziyrek
SKSerkan Kahraman
Serkan Kahraman
EOEmrah Ozdemir
Emrah Ozdemir
ADAli Dogan
Ali Dogan

17 February 2024 in Advances in Medical Sciences
Verified
Journal Article
Closed access
EOEmrah Ozdemir
Emrah Ozdemir
BSBerna Stavileci
Berna Stavileci
BOBahar Ozdemir
Bahar Ozdemir
FAFaik Alper Aksoy
Faik Alper Aksoy
SKSerkan Kahraman
Serkan Kahraman
ADAli Dogan
Ali Dogan

1 May 2021 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
MIMehmet Sami Islamoglu
Mehmet Sami Islamoglu
MDMehmet Dokur
Mehmet Dokur
EOEmrah Ozdemir
Emrah Ozdemir
OUOmer Faruk Unal
Omer Faruk Unal
Background: Venous thromboembolism clinically presenting with a deep vein thrombosis or pulmonary embolism is among the most commonly seen cardiovascular syndromes. The aim of this case presentation is to emphasise the typical electrocardiographic findings that are detected with massive pulmonary embolism along with the electrocardiographic S1Q3 and S1Q3T3 accompanied by T negativity at the D3 derivation based on prevalent T negativity.Case presentation: We present the case of an adult male who presented with a massive pulmonary embolism that was associated with tachycardia, haemoptysis and typical S1Q3T3 electrocardiographic findings. Tomographic findings showed filling defects in the two main pulmonary artery lumens, which were found to be compatible with a massive embolism. Intravenous heparin was injected (5000 IU), and low molecule weight heparin (LMWH) treatment was initiated. After two days of observation and treatment in the coronary intensive care unit, the patient was discharged for outpatient care.Discussion: Massive pulmonary embolism is an urgent life-threatening clinical situation that is frequently confused with acute ST elevation myocardial infarction. The definitive diagnosis of massive pulmonary embolism was made with a computed tomography pulmonary angiogram. Electrocardiographic findings and hypoxic hypercarbia in the blood gas analysis are typical. Early diagnosis with laboratory and imaging investigations is vital in the treatment and prognosis of pulmonary embolism.Conclusions: Ventricular overload signs accompanied by ST segment elevation in electrocardiography and S1Q3 and prevalent T negativity are crucial features in terms of distinguishing between pulmonary embolism and myocardial infarction and selecting effective treatments for patients admitted to the emergency department.

19 September 2025 in Medicine
Verified
Journal Article
Open access
EOEmrah Ozdemir
Emrah Ozdemir
MZMurat Ziyrek
Murat Ziyrek
Members of the transforming growth factor-β superfamily, such as growth differentiation factor 15 (GDF-15), are potent regulators of vascular remodeling and play key roles in atherosclerosis. In this study, we investigated the effect of GDF-15 level on the extent and severity of atherosclerosis in patients with peripheral artery disease (PAD) without obstructive coronary artery disease. A total of 130 patients with PAD who were admitted to the cardiology outpatient department of Biruni University Health Center with complaints of chest pain and intermittent claudication, and whose coronary artery disease was excluded after coronary angiography, were included. GDF-15 levels were measured, and the TASC-2, Rutherford, and Fontaine classifications of patients with obstructive PAD patients were performed. Although there were no statistically significance between 5 Fontaine classes, 3 categories of Rutherford classification and 4 groups of TASC-2 in terms of BMI, platelet count, monocyte/HDL ratio, CRP, and GDF-15 levels were significantly increased. Furthermore, we also performed a regression analysis of parameters that reached statistical significance between the PAD(+) and PAD(−) groups to analyze the independent risk factors for obstructive PAD and lower extremity ulcers. Although none of the mentioned parameters were found to be independent risk factors for obstructive PAD, CRP ([P = .006, β: 1.098, OR [(95% CI): 1.027–1.174]) and GDF-15 ([P = .002, β: 1.002, OR [(95% CI): 1.004–1.010]) were shown to be independent risk factors for lower- extremity ulcers. Our prospective study postulated that CRP and GDF-15 levels are elevated in patients with obstructive PAD and they are independent risk factors for lower-extremity ulcers.

24 June 2024 in Blood Pressure Monitoring
Verified
Journal Article
Closed access
EOEmrah Ozdemir
Emrah Ozdemir
BSBerna Stavileci
Berna Stavileci
BOBahar Ozdemir
Bahar Ozdemir
FAFaik Alper Aksoy
Faik Alper Aksoy
CGCeyla Zeynep Colakoglu Gevher
Ceyla Zeynep Colakoglu Gevher
MZMurat Ziyrek
Murat Ziyrek
Aim: ST2 receptor is a member of toll-like/interleukin-1 receptor family. After the activation of IL-33/ST2 signaling pathway clinically detectable amount of soluble form of ST2 (sST2) is released into the circulation. Previous studies showed that sST2 levels were significantly higher in hypertension patients than in controls. In this prospective study, we aimed to analyze this relation and test the predictive accuracy of the sST2 level in diagnosis of nondipping hypertension in newly diagnosed hypertension patients. Methods: Three hundred thirty-seven patients (150 normal, 187 hypertension) who presented with symptoms of hypertension were included in the study. All patients underwent 24-h ambulatory blood pressure monitoring and sST2 measurement. Results: Of 187 hypertension patients, 92 of them had nondipping and 95 of them had dipping pattern. sST2 level was significantly higher in nondipping group compared to dipping group and control group (40.79 ± 7.77 vs. 32.47 ± 6.68; P < 0.0001 and 40.79 ± 7.77 vs. 20.09 ± 7.09; P < 0.0001 respectively). Binary logistic regression analysis revealed that; only sST2 level was an independent risk factor for hypertension [P < 0.0001, β: 1.258, odds ratio (OR) (95% confidence interval (CI)): 1.158–1.366]. and also nondipping hypertension [P < 0.0001, β: 1.208, OR (95% CI): 1.108–1.317]. Conclusion: Based on the present study it could be concluded that sST2 level is significantly associated with the newly diagnosed hypertension and nondipping hypertension. Hence it could reliably be used to diagnose hypertension and nondipping hypertension with high sensitivity and specificity.